Pecan Consumption and Cognitive Function
Cognitive Function in Response to a Pecan-Enriched Meal
1 other identifier
interventional
31
1 country
1
Brief Summary
Human cognitive function is affected by age-related changes, with some areas beginning to decline in mid-adulthood and worsening with age. However, there is evidence that dietary interventions or the incorporation of certain healthy foods or nutrients, into the diet can have protective effects against cognitive decline. These foods include nutrients such as polyunsaturated fats, vitamins E and C, and polyphenols. Pecans are a rich source of polyunsaturated fatty acids, antioxidants (including polyphenols), and vitamin E. Pecans contain more total phenols than any other tree nut suggesting that they may be an ideal bioactive food to enhance cognitive performance; however, the relationship between pecan consumption and cognitive functioning has never been assessed. The overall goal behind this research is to determine the relationship between antioxidant-rich pecans and cognitive functioning in a postprandial state.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Feb 2021
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 22, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2023
CompletedApril 14, 2023
April 1, 2023
2.1 years
January 22, 2022
April 12, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Alphabetic Working Memory, Choice Reaction Time, Digit Vigilance, N-back test, Word Recognition, Rapid Visual Information Processing, Picture Recognition, Immediate Word Recall, and Delayed Word Recall
Measured by Computerized Mental Performance Assessment System (COMPASS) computed scores of percent accuracy (total overall target stimuli/novel stimuli) Brain, Performance, and Nutrition Research Centre, Northumbria University
Change from baseline to 4 hours postprandially
Change in Serial Subtractions, Immediate Word Recall, and Delayed Word Recall.
Measured by Computerized Mental Performance Assessment System (COMPASS) computed scores of the number of responses (total correct responses/error responses) Brain, Performance, and Nutrition Research Centre, Northumbria University
Change from baseline to 4 hours postprandially
Change in Alphabetic Working Memory, Choice Reaction Time, Digit Vigilance, N-back, Picture Recognition, Rapid Visual Information Processing, Word Recognition.
Measured by Computerized Mental Performance Assessment System (COMPASS) computed scores of reaction time (msec) (overall, correct response, target stimuli, novel stimuli, number of false alarms, and number of missed sequences) Brain, Performance, and Nutrition Research Centre, Northumbria University
Change from baseline to 4 hours postprandially
Secondary Outcomes (9)
Change in glucose and triglycerides
Change from baseline to 4 hours postprandially
Change in physiologic measures of appetite
Change from baseline to 4 hours postprandially
Change in lipid peroxidation
Change from baseline to 4 hours postprandially
Change in insulin
Change from baseline to 4 hours postprandially
Change in non-esterified free fatty acids (NEFA)
Change from baseline to 4 hours postprandially
- +4 more secondary outcomes
Other Outcomes (3)
Change in subjective measures of motivation
Change from baseline to 4 hours postprandially
Change in subjective measures of alertness, stress, and tranquility
Change from baseline to 4 hours postprandially
Change in subjective degree of sleepiness
Change from baseline to 4 hours postprandially
Study Arms (2)
Pecan Breakfast Shake
EXPERIMENTALParticipants will be given a breakfast shake consisting primarily of pecans, and 1% milk.
Cream Breakfast Shake
ACTIVE COMPARATORParticipants will be given a breakfast shake consisting primarily of heavy whipping cream.
Interventions
The pecan breakfast shake contains 68 grams of blended raw pecans. Participants will consume this shake at either visit 1 or visit 2 depending on randomization procedures.
The cream breakfast shake contains 138 grams of heavy whipping cream. Participants will consume this shake at either visit 1 or visit 2 depending on randomization procedures.
Eligibility Criteria
You may qualify if:
- to 30-years-old
- Healthy individuals
- Men and Women
- Normal body mass index (BMI) (18.5-24.9kg/m2). If BMI is 25 or greater, subjects can still qualify if their body fat percentage falls within healthy ranges defined as Men: 5-20%, and Women: 15-30% \[22\]
- Individuals with normal or corrected to normal vision
- Low-risk alcohol use as assessed by the AUDIT questionnaire (need a score of 7 or lower)
- No or minimal depression symptoms as indicated by the Beck's Depression Inventory (need a score of 9 or lower)
- Cognitive competence for education level and age as measured by the Mini-Mental State Examination (need a score of 26 or higher)
You may not qualify if:
- All chronic diseases (including, but not limited to, renal or bowel diseases, cardiovascular disease, and any form of diabetes)
- Known neurological, cognitive, or psychiatric conditions (including, but not limited to, mood disorders, anxiety disorders, and depression)
- Prescription medication use (with the exception of female contraception methods)
- Dietary supplement use (including, but not limited to, multivitamins and fish oil supplements)
- Alcohol intake \>3 drinks/d for males or \>2 drinks/d for females
- Diagnosis of ADHD or a learning difficulty (including, but not limited to, dyslexia)
- History of head injury (defined as loss of consciousness more than 10 minutes)
- History of inflammatory disorders (including, but not limited to, migraines, stroke, hypertension, hypercoagulation, vascular disease, thyroid conditions, blood disorders, coagulation disorders)
- Food allergies/sensitivities to foods provided in this protocol including tree nuts, gluten, and or lactose/dairy
- Regular consumption of nuts and/or nut butters defined as consumption of \>2 servings (60g) of tree nuts or nut butters (e.g., peanut butter, almond butter) per week
- High caffeine consumption, defined as \>400mg/d
- Individuals adhering to special diets (including, but not limited to, the ketogenic diet, intermittent fasting, Atkins diet, vegan diet, vegetarian diet, or carbohydrate-restricted diets)
- Illicit drug use
- Smoking or use of tobacco products
- Color-blindness
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Georgia- Department of Foods and Nutrition
Athens, Georgia, 30605, United States
Related Publications (2)
Guadagni AJ, Prater MC, Paton CM, Cooper JA. Cognitive function in response to a pecan-enriched meal: a randomized, double-blind, cross-over study in healthy adults. Nutr Neurosci. 2025 Sep;28(9):1075-1092. doi: 10.1080/1028415X.2025.2461018. Epub 2025 Feb 13.
PMID: 39945748DERIVEDPrater MC, Guadagni AJ, Cooper JA. Postprandial appetite responses to a pecan enriched meal: A randomized crossover trial. Appetite. 2024 Oct 1;201:107598. doi: 10.1016/j.appet.2024.107598. Epub 2024 Jul 4.
PMID: 38971424DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie A Cooper, PhD
University of Georgia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Involved researchers and participants are blinded to which breakfast shake they are administering and/or receiving.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 22, 2022
First Posted
February 8, 2022
Study Start
February 1, 2021
Primary Completion
February 25, 2023
Study Completion
February 25, 2023
Last Updated
April 14, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
The plan is to share group averages through publication.